Notes - Significant Accounting Policies For Preparation Of Semi-Annual Consolidated Financial Statements

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7738142

Concept 2016-04-01 to
2017-03-31
As at
2017-03-31
Notes - Significant accounting policies for preparation of semi-annual consolidated financial statements
Notes - Significant accounting policies for preparation of semi-annual consolidated financial statements
Disclosure of scope of consolidation
Number of consolidated subsidiaries and names of major consolidated subsidiaries

1 連結の範囲に関する事項

連結子会社の数         1社

連結子会社の名称   科研ファルマ㈱

 

Number of consolidated subsidiaries
1 xbrli:pure
Disclosure about application of equity method
Number of unconsolidated subsidiaries and associates accounted for using equity method and names of major entities accounted for using equity method

2 持分法の適用に関する事項

  持分法適用の関連会社数  ―社

 持分法非適用の関連会社はありません。

 

Number of associates accounted for using equity method
xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.